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but High Dimensional Omic Data:
Applications to GWAS/EWAS and More
Sara Kherad Pajouh, Alan E. Hubbard, and Martyn T. Smith
Abstract
Exploratory analysis of high dimensional “omics” data has received much at-
tention since the explosion of high-throughput technology allows simultaneous
screening of tens of thousands of characteristics (genomics, metabolomics, pro-
teomics, adducts, etc., etc.). Part of this trend has been an increase in the di-
mension of exposure data in studies of environmental exposure and associated
biomarkers. Though some of the general approaches, such as GWAS, are trans-
ferable, what has received less focus is 1) how to derive estimation of indepen-
dent associations in the context of many competing causes, without resorting to a
misspecified model, and 2) how to derive accurate small-sample inference when
data adaptive techniques are used in this context. This paper focuses on semi-
parametric variable importance analysis of high dimensional data sets of modest
sample size (e.g., gene expression, mRNA, etc). Though the methodology we
propose is generally applicable to similar situations, we present the method in the
context of a study of miRNA expression for an environmental exposure. Specifi-
cally, the analysis is faced with not just a large number of comparisons, but also
trying to tease out of association of the expression of miRNA with an exposure
apart from confounds such as age, race, smoking conditions, BMI, etc. Our goal
is to propose a method that is reasonably robust in small samples, but does not
rely on misspecified (arbitrary) parametric assumptions, and thus will be based
on data-adaptive methods. The methodology proposed is we believe a powerful
combination of existing semi-parametric statistical methods and theory, as well
as a simple framework for use of commonly used empirical Bayes approaches to
aid in small sample inference. Specifically, We propose using targeted maximum
likelihood estimation (TMLE) for estimating variable importance measures along
with a general adaptation of the commonly used Limma approach, which relies on
specification of the so-called influence curve of the proposed estimator. The result
is a machine-based approach that can estimate independent associations in high
dimensional data, but protects against the unreliability of small-sample inference
that can result when using data adaptive estimation in relatively small samples.
1 Introduction
New methods are needed for evaluating both a rich variety of potential environmen-
tal exposures, along with the growing number of methods for producing biomarkers
- so called more robust methods of Exposome or Environment Wide Association
Studies (EWAS; Rappaport and Smith (2010) and Rappaport (2012) ). There has
been an effort to incorporate the types of methodologies used in similar data struc-
tures, for instance, Genome Wide Association Studies (GWAS; Manolio (2010)).
For instance, Patel et al. (2010) has used fairly standard methods of parametric
models with adjustments for multiple testing to rank potential environmental con-
tributors to type 2 diabetes. However, as emphasized by Rappaport and Smith
(2010), to thoroughly study the many facets of the exposome simultaneously, takes
a complicated high dimensional situation and increases the dimensionality (more
things to measure and associate with potential downstream effects of exposure). In
this context, we will need data adaptive tools, that can be developed to target spe-
cific parameters related to the scientific questions posed by studying the exposome,
avoiding bias automatically introduced by the use of parametric models. In this
paper, we expand on an idea originally presented for an EWAS study of childhood
exposures and later development, proposing a new combination of automated semi-
parametric estimation and inferential methods to assess the relative ”importance”
of potential biomarkers in high dimensional, but relatively small data sets. The
methodology can be adapted to almost any situation, in this case we discussed es-
timating variable importance in the context of a binary variable of interest (in our
case exposure to a potential environmental toxin) and potentially many confound-
ing variables. We present the method by analyzing miRNA expression array across
subjects of different measured characteristics, but it obviously has the potential for
use in for a very general data structure involving finding the impacts of specific
factors among a large suite of candidates. However, one of the obvious dangers of
data adaptive methods used in combination with very high dimensional data with
relatively small samples sizes is the potential for spurious false positive findings, a
potential epidemic which is occurring in the general field of high dimensional biology
(e.g., see Ioannidis (2005)). However, we present a methodology that can at least
avoid errors of analysis assuming a misspecified parametric model, and in a field
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of study where the dimension, and thus potential for false positives, will also grow
without the use of more rigorous methods. Thus, we propose a semi-parametric
(data-adaptive) method, that still can provide trustworthy robust inference, as well
as the flexibility to target parameters that directly address the scientific question of
interest.
Parametric or non-parametric (for simple comparisons across groups) methods
have been widely studied in the literature by applying standard statistical tests per-
haps with robust inference. When the estimation of the association of biomarkers
involve adjustment of potential confounders, researchers have typically parametric
regression models (e.g. Wang et al. (2012) and references therein). Though co-
efficients of linear model, multiple regression, or some other parametric methods
have been considered natural candidates to measure the relationships of interest,
these methods suffer from arbitrary assumptions (biased statistical models) of the
data generating, since one typically knows very little in these circumstances about
true probability distribution. In fact, though typically ignored, assuming an un-
derlying model to make inference for the parameter may be misleading, claiming a
certainty that does not exist. When the model is unknown, the dimension of the
problem large, and the sample size small (often the case in studies of biomarkers),
then data adaptive methods are warranted (nonparametric methods are impossible,
and parametric methods unjustified). Such data adaptive methods, e.g., machine
learning, avoids misspecification of the statistical model (since they are very large),
but, at first blush, do not directly provide simple summary measures of the variable
importance.
The methods of this paper are inspired by the goal of determining which mea-
sures (e.g., biomarkers) have the greatest independent association with some trait
of interest, such as exposure to a potential toxin. In a simple motivating data set,
we use differentially expressed miRNA’s between two groups of exposed and non-
exposed workers, by considering the all confounders of exposure in the model. As
done in (Young et al. (2012)) the parameter of interest used is the average treatment
(or exposure) effect (Holland (1986)) inspired by the causal inference literature, but
can also be defined as a statistical parameter: the difference between conditional
expectations of the outcome given different levels of treatment effect and covariates
for each subject, averaged across all subjects (Bembom et al. (2008)). The particu-
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lar estimator emphasized is a substitution estimator based on Targeted Maximum
Likelihood Estimation (TMLE; Van der Laan and Rose (2011)).
Because the goal is to yield an algorithm that can be applied in automated
fashion to find the relative importance of competing biomarkers in an unspecified
statistical model, we concentrate on inferential methods for the TMLE estimates
that are robust for small sample sizes, even when aggressive data adapted tools are
used. As discussed below, one of the great advantages of TMLE is that the esti-
mators can be so-called asymptotically linear (and thus normally distributed) with
easy calculated standard errors ( based on the influence curve). While these SE’s are
computationally inexpensive to derive, they can be unstable in small sample sizes.
Thus, we introduce a general method of combining the empirical Bayesian method,
(Smyth, 2005a), with influenced curve based inference, to derive more robust gen-
eral methodology in finite sample sizes. The result is a computationally efficient,
automated method for deriving the joint inference in a very large (semi parametric)
statistical model of many related exposome measures.
In section 2, we introduce our propose methodology, by first motivating our
methodology via a omic study of occupational exposure. We then outline the de-
tailed steps of the method, from formally defining the data and the target param-
eter of interest, to estimating the statistical model using data-adaptive approaches
(SuperLearner), to using the resulting prediction model to optimally estimate, via
Targeted Maximum Likelihood, the variable importance measure.
We then present a generalization of Limma that can be used for the estimates
of these type of variable importance measures. In section 3, we apply the proposed
methodology to the example study, and we finish in section 4 with a discussion.
2 Methods
2.1 Data Structure
MicroRNAs (miRNA) are single-stranded RNA molecules of about 21-23 nucleotides
in length, which regulate gene expression. In this study our aim is to find out the
association of miRNA expression between an exposure in 18 subjects (20 samples, 2
technical replicates), from a study of occupational exposure in factories in Tianjin,
3
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China (McHale et al., 2011) and Lan et al. (2004). The miRNA expression was
measured by Affymetrix GeneChip miRNA 2.0 microarrays based on 4592 probes
specific to Homo Sapiens small RNAs, including miRNAs. Among the 18 subjects,
11 were exposed and the rest were unexposed controls. We considered 5 potential
confounding factors: age, gender, BMI, cigarette smoking, and alcohol use.
In this example, our aim is to find the association of an environmental exposure
on the gene expression of 4592 probes (miRNA) simultaneously and about some
complicated situations and the challenging part which is due to the small sample
sizes with existing of confounders in the model. This could be easily generalized to
situations where one has a greater number of potential exposure biomarkers, as well
as other confounding variables.
2.2 Defining the model and targeted parameter
The aim of analyzing these datasets is to rank the importance of a set of candi-
date biomarkers with regards to their independent association with the outcome
(exposure in this case). In order to find a method for ranking biomarkers, we
define a so-called variable importance measure (VIM) (Van der Laan and Rose,
2011). Let O = (W,A, Y ) ∼ P0 represent a random variable regarding the observed
data, where W are the corresponding confounders, A is the exposure of interest,
Y is a vector of potential biomarkers (Y = (Yb, b = 1, .., B)), and P0 be the corre-
sponding unknown probability distribution of the data. For our specific data set,
W = W1,W2,W3,W4,W5 where factor age (W1) is continuous measure, gender (W2)
is binary, smoking situation (W3) binary, BMI (W4) is continuous measure and al-
cohol consumption (W5) is a binary variable, A is binary exposure (yes=1, no=0),
and Yb are, one at a time, the miRNA expression values.
First, as a general definition of a parameter, consider Ψ(P0) be the target pa-
rameter according some function Ψ that maps the probability distribution P0 in
to the target feature of interest. The parameter Ψ(P0) is a function of the un-
known probability distribution P0. If Pn represents the empirical distribution of the
O1, O2, ..., On, we are interested in the substitution estimators of the form Ψ(Pn),
that is we apply the same mapping but to the empirical distribution, to derive our
estimate. Thus, we expand the parameters of interest beyond coefficients in a typi-
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cally arbitrary (and certainly misspecified) parametric statistical model, to define a
parameter as a feature of the true probability distribution P0 of the data using true
knowledge we have about P0. Specifically, we propose here what we refer to as a
targeted variable importance measure (VIM)(Bembom et al., 2008):
Ψb = Ψb(P0) = EW [E0(Yb|A = 1,W )− E0(Yb|A = 0,W )]. (1)
Note that under identifiability assumptions, such as no unmeasured confounding,
that this parameter of the statistical model identifies a parameter of a causal model,
specifically Ψ(P0)b = E[Yb(a = 1) − Yb(a = 0)], or the differences in the mean of
the biomarker in the population had everyone been exposed minus the mean had no
one been exposed (Pearl, 2000). This is referred to as the average treatment effect
(Rosenbaum and Rubin, 1983). The significance of this is that such parameters are
not defined via a parametric model, and so one is free then to fit the model based
on few if any assumptions; thus, one can use data-adaptive methods and still report
the estimate of a relatively simple parameter.
2.3 Estimation
The targeted parameter is defined as a feature of the unknown probability distribu-
tion P0 in Section 2.2, and the next step is to making inference about this parameter.
There are general classes of estimators available for estimating Ψ. Here we focus on a
substitution estimator (that is estimate 1 plugging estimates for Q and the empirical
for P0(W )), where the estimate of Q
b
0(A,W ) ≡ E0(Yb|A,W ) is based on TMLE (Tar-
geted Maximum Likelihood Estimator ) Gruber and Van Der Laan (2009). TMLE
is a two stage estimation procedure, in which an initial estimate of Q0 is updated
(in the 2nd step) before deriving the substitution estimator,
Ψ(Pn)b =
1
n
n∑
i=1
Qbn(1,Wi)−Qbn(0,Wi) (2)
where Qbn represents an estimate of Q
b
0.
5
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2.3.1 SuperLearning
The first step in this two-stage estimator is to derive an initial estimate of Qb0,
referred to as Q
(b,0)
n . One could, for instance, assume a parametric statistical model
that results, for instance, 1 being equivalent to a coefficient (e.g., Qb0(A,W ) =
αb + βbAA + β
b
WW ). However, given that 1 is defined in a nonparametric model,
there’s little sense in estimating with a misspecified regression model, when tools
exists to data-adaptively estimate Qb0 in a much bigger model. Specifically, given
that the model Qb0 is typically unknown, one should be able to derive less biased
estimates by applying available machine learning algorithms, many of them imply
a (near) nonparametric statistical model for Qb.
However, this raises the issue of which data-adaptive algorithm is optimal, and
no such theory exists for any one ”learner”. However, there is theory to support a
procedure that examines a multitude of candidates. Specifically, the SuperLearner
(SL) algorithm, which is a so-called stacking algorithm implemented as a cross-
validated selector, that produces a estimate which is an optimally weighted (to
minimize the cross-validated risk) the predictions from a set of candidate algorithms.
These algorithms can very from very simple/smooth to highly data-adaptive (Van
Der Laan et al., 2007).
Though the set of candidates is somewhat arbitrary, the theory developed behind
SL (the Oracle Inequality) offers some guidance as to the type and number of candi-
dates one should consider in the fitting routine. Specifically, if one of the candidate
learners is actually the true model and converges at a parametric rate, the SL will
converge at an close to parametric rate. In general, the SL will do, in first order,
do as well (in terms of risk) as an algorithm that chooses the particular candidate
learner based on knowing the true distribution (that is, the Oracle Selector), and
this result holds as long as the number of candidates is on the order of a polynomial
in sample size. Thus the SL theory encourages the use of a very large number of
possible learning algorithms and ones that vary from very smooth, to aggressively
data-adaptive. The SL algorithm is available as a statistical package (Polley and
van der Laan, 2012) in the R programming language (Ihaka and Gentleman, 1996).
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2.3.2 TMLE
The SL estimate of Q0 is done to minimize the cross-validated risk, based on some
loss-function (such as squared error, or -log likelihood), that is not the target of
the analysis, which is to minimize the mean-squared error of Ψb. In addition, there
is no guarantee that given a set of highly data-adaptive learners used by the SL,
that the estimate of Ψb, particularly for a relatively small sample size, has a normal
sampling distribution. Fortunately, Van der Laan and Rose (2011) introduced an
estimator for Q0, that ”targets” the estimate of the regression, towards the particu-
lar parameter of interest, and also ”smooths” the estimator such that the sampling
distribution converges more quickly to a normal distribution. In addition, this tar-
geting step can be thought of as a bias reduction step, given that data-adaptive
selection represented by SL can result in an estimate of Ψb that suffers from residual
confounding. This can occur, for instance, if selection of the variables in a pro-
cedure for estimating Qb0 leaves out some regressors that are truly confounders of
the association of A and Y . The resulting estimator is also more robust to model
misspecification than the substitution estimator based on the initial SL fit, as well
as being semi-parametrically locally efficient. For a full explanation of the theory
behind TMLE and the formal justification of the estimator as most efficient among
a class of estimators in a semiparametric model, see the appendix of Van der Laan
and Rose (2011).
Algorithmically, the TMLE estimator in this context is a simple one-dimensional
augmentation of the initial fit. Specifically, to the SL fit, if the outcome is continuous,
one fits a simple, one-dimensional regression of type:
Q(b,1)n (A,W ) = Q
(b,0)
n (A,W ) + hgˆ(A,W ),
where the initial fit, Q
(b,0)
n (A,W ) is treated as an offset, and hgˆ(A,W ) is a covariate:
hgˆ(A,W ) =
I(A = 1)
gˆ(1|W ) −
I(A = 0)
gˆ(0|W )
where gˆ(1|W ) is an estimate of the P (A = 1 | W ) or the propensity score (Rosen-
baum and Rubin, 1983). The selection of gˆ can also be made by a process that
minimizes the mean-squared error of the parameter of interest (Gruber and Van
7
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Der Laan, 2010), but in this case, we use simple main terms logistic regression. Fi-
nally, one derives the final TMLE estimate of the Ψb using the augmented estimate
of Q, or
Ψˆb(Pn) =
1
n
n∑
i=1
[Q(b,1)n (1,Wi)−Q(b,1)n (0,Wi)]. (3)
2.4 Inference
As shown in Van der Laan and Rose (2011), Ψˆb(Pn) of Ψb is asymptotically linear
with influence curve IC(O) if it satisfies
√
n(Ψb(Pn)−Ψb(P0)) = 1√
n
n∑
i=1
IC(Oi) + op(1). (4)
Thus, in other words, the variance of Ψˆb(Pn) is well approximated by sample variance
of the influence curve divided by the sample size, n. In this case, the plug-in influence
curve (IC) for the ATE is:
ICb,n(Oi) =
(
I(Ai = 1)
gn(1|Wi) −
I(Ai = 0)
gn(0|Wi)
)
(Yb,i −Q(b,1)n (Ai,Wi)) +Q(b,1)n (1,Wi)
−Q(b,1)n (0,Wi)−Ψb(Pn). (5)
Finally, we can derive asymptotic p-values and confidence intervals using a Wald
type approach, or
pvalue = 2
[
1− Φ( |Ψb(Pn)|
σbn/
√
n
)
]
95 % CI = Ψb(Pn)± 1.96σbn/
√
n,
where σbn is the sample standard deviation of the ICb and Φ(·) is the cumulative
standard normal distribution.
2.4.1 Limma Applied to Influence Curve-Based Inference
By applying directly the TMLE estimator of targeted parameter, using data adap-
tive methods in small samples, one will often face high unstable standard error
8
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estimation, so that the joint inference of this targeted variable importance measure
can result in erroneously significant biomarkers. Thus, we want a technique that
asymptotically provides the correct inference, but in small samples, can “borrow”
information across the many estimates of sampling variability (the σbn), to provide
more robust finite sample inference. Fortunately, an established empirical Bayes
technique, developed for high dimensional situations (such as one involving 1000’s
of candidate biomarkers) accomplishes this twin goals. Specifically, we propose the
Limma approach for improving the finite sample performance for the inference about
targeted parameter. Limma is package in R which use linear model for microarray
data by using empirical Bayes (Smyth et al., 2004). Limma borrows information
across all genes and make more stable and robust inference for microarray data
(Smyth, 2005a). In Section 2 we explained that a common way of making inference
about the targeted parameter Ψb, (for the enough sample size), is to find the influ-
ence curve values for Ψb. Then by calculating the corresponding standard errors of
the influence curve of Ψb and finding the corresponding p-values based on that and
making inference about Ψb for each probe. We used Limma package for the applying
empirical Bayes inference for all probes based on (Smyth, 2005b) as the following
steps:
• Find influence curve for each probe, and find the corresponding matrix of
influence curve for all subjects and all probes.
• Add the Ψb(Pn) estimate to each row of the mean zero influence curve matrix,
to get a row that has as simple sample average, Ψb(Pn), but whose variance is
the sample variance of the ICb.
• Perform Limma on this matrix (assuming estimating the simple mean),
• Use the resulting inference, based on the shrinkage estimate of the sampling
standard deviation of the influence curve, σ˜bn which is a weighted average of
σbn and a value close to the average of all these sample standard deviation esti-
mates across the biomarkers, or σbn ≈ 1B
∑B
b=1 σ
b
n, or σ˜
b
n = wtbσ
b
n + (1−wtb)σbn,
where the wtb is between (0,1). see Smyth (2005a) for formal presentation. As
n→∞, wtb → 1, and so σ˜bn → σbn
9
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• Use multiple testing corrections to make inference about all probes. Here we
used False Discovery Rate (FDR) correction.
Thus, this procedure will shrink aberrant values variability estimates toward the
center of the distribution, particularly if the sample sizes is relative small. The
practical effect is that it tends to reduce the number of significant biomarkers, driven
by (potentially) erroneous underestimate of variation of the parameter estimates of
interest, Ψb(Pn).
3 Data Analysis
3.1 miRNA
For the miRNA dataset in 2.1, we first applied a standard, linear model approach
to get the VIM, using Limma as well. We show these results in Table 3.1.1, where
for each method we calculated the parameter estimate (coefficient correspond to
exposure in linear model), standard errors of the coefficient, original p-values and
the corresponding adjusted p-values or q-values based on BH correction (Benjamini
and Hochberg, 1995) for top 10 more important biomarkers.
Then we made inference about miRNA dataset based on the semiparametric
method using TMLE 2.3.2 as well as adapting of empirical Bayes Limma method,
that introduced in chapter 2.4.1. We used TMLE package in R which is introduced
by Gruber and van der Laan (2012), and we used stepwise generalized linear models
and choose the best model in a stepwise algorithm. If one had a relatively larger
sample size, then a larger set of more flexible algorithms would be added.
As in the case for the simple linear model, we performed BH multiple testing
procedure to find the significant probes. We show the results in Table 3.1.1 where we
calculated the estimation of targeted parameter, standard error of parameter, origi-
nal p-values and the corresponding q-values for both methods, after BH corrections
for all probes. the results are shown for top 10 most significant probes.
10
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Figure 1: P-values of top 10 significant probes according to TMLE and
Limma for IC of Ψ
3.1.1 Results
The results show that applying parametric linear regression model and also Limma
for testing the corresponding parameter gives no significant Probes and inference
based on TMLE estimation there are 23 significant probes at 5% of significant level
and by applying Limma package on the matrix of influence curve added by estima-
tion of Ψb effect, there are only 2 significant probes at 10% of significant level. In
Figure 3.1.1 we compare the significant probes based on two methods. The results
suggest that the shrinkage estimator using Limma for targeted parameter, provides
more conservative inference for the targeted parameter, relative than directly using
just σbn based only on the IC within one biomarker, b.
As expected, Limma reduced the spread of the standard deviation estimates
of the IC (σ˜bn) across the 4952 probes, and the corresponding Wald-statistics for
testing the targeted parameter, in comparison of using the original standard error,
σbn. In Figure 3.1.1 we compare the boxplots of Wald-statistics between two methods
for top significant probes. Thus using directly TMLE for the small sample size of
subjects leads many significant probes that may comes from variability of standard
errors estimated by influence curve and adapting TMLE by Limma will reduce the
variability of standard errors and reduce the number of significant probes which
leads to the more robust inference.
11
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Figure 2: Comparison of variability of standard errors for top 10 signif-
icant probes, according to TMLE estimation based on TMLE (Standard) and
TMLE (Limma)
3.2 Genomic Example
We performed simulations using mRNA data generated from subjects in the ben-
zene occupational study, 59 shoe factory workers exposed to benzene (1<ppm ) and
42 healthy unexposed control clothing factory workers McHale et al. (2011). First,
we calculated statistical inference for all subjects using both methods. According
to TMLE, differential expression of 2188 probes was found to be significant. Ac-
cording to Limma, 2086 significant probes were found after multiple test correction
FDR (BH), treating these set as the set of “true” differentially expressed probes.We
then randomly sampled from the list of arrays and re-did the analysis. This was
repeated randomly as different sample for equal numbers of exposed vs. controls
(n = 8, 15, 20, 25, 30) and, we report the performance (overlap) relative to the set
found with all original samples (59 exposed, 42 controls).
12
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Table 1: Top 10 table of probes listing for testing the effect of exposure
based on Linear model estimation according to standard Linear model and
Limma inference. SE, p and q are corresponding to standard error of regression
parameter (ΨLM ) and corresponding p-values and q-values (adjusted p-values
after BH correction)
Linear Model (standard) Linear Model (Limma)
ΨˆLM SE p q ΨˆLM SE p q
Prob 1 0.36 0.08 1× 10−3 >0.10 0.36 0.04 1× 10−3 >0.10
Probe 2 0.55 0.13 1× 10−3 >0.10 0.55 0.07 1× 10−3 >0.10
Probe 3 0.25 0.06 1× 10−2 >0.10 0.25 0.03 1× 10−2 >0.10
Probe 4 0.35 0.09 1× 10−2 >0.10 0.35 0.05 1× 10−2 >0.10
Probe 5 0.45 0.13 1× 10−2 >0.10 0.45 0.07 1× 10−2 >0.10
Probe 6 -1.14 0.33 1× 10−2 >0.10 -1.14 0.42 1× 10−2 >0.10
Probe 7 0.40 0.11 1× 10−2 >0.10 0.40 0.06 1× 10−2 >0.10
Probe 8 -0.68 0.20 1× 10−2 >0.10 -0.68 0.16 1× 10−2 >0.10
Probe 9 0.83 0.24 1× 10−2 >0.10 0.83 0.23 1× 10−2 >0.10
Probe 10 0.70 0.22 1× 10−2 >0.10 0.70 0.18 1× 10−2 >0.10
3.2.1 Results
In Table 3.2.1 the simulation is based on one draw for each sample size and shows
that at small sample sizes the number of significantly differentially expressed probes
decreases dramatically using the standard IC-based inference, versus adding the
Limma approach, which also means a much lower false positive rate. This difference
continues at larger sample sizes, but not as dramatically, as difference of Limma
versus standard estimates of the IC’s by probe diminishes. Though not a simulation
from a known true distribution, this shows the potential danger of using IC-based
inference with aggressive data-adaptive procedures at small sample sizes, and the
benefit of Limma to make these inferences much more robust.
13
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Table 2: Top 10 table of probes listing for testing the effect of exposure
based on Targeted Maximum Likelihood Estimation according to TMLE and
TMLE adjusted by Limma inference . SE, p and q are corresponding to both
the non-altered initial sampling standard deviation of the IC, σbn, and that
corresponding to the Limma estimate, σ˜bn, p-values, and q-values (adjusted
p-values after BH correction)
TMLE (σbn) TMLE (Limma; σ˜
b
n)
ΨˆTMLE SE p q SE p q
Probe 1 0.36 0.29 1× 10−9 <0.05 0.11 1× 10−5 <0.10
Probe 2 0.56 0.47 1× 10−7 <0.05 0.23 1× 10−5 <0.10
Probe 3 0.24 0.23 1× 10−6 <0.05 0.09 1× 10−4 >0.10
Probe 4 0.33 0.33 1× 10−6 <0.05 0.13 1× 10−4 >0.10
Probe 5 0.47 0.49 1× 10−5 <0.05 0.24 1× 10−4 >0.10
Probe 6 -1.23 1.31 1× 10−5 <0.05 1.28 1× 10−4 >0.10
Probe 7 0.40 0.43 1× 10−5 <0.05 0.20 1× 10−4 >0.10
Probe 8 -0.76 0.80 1× 10−5 <0.05 0.58 1× 10−4 >0.10
Probe 9 0.84 0.92 1× 10−4 <0.05 0.75 1× 10−4 >0.10
Probe 10 0.71 0.77 1× 10−4 <0.05 0.54 1× 10−4 >0.10
4 Discussion
The goal of this paper is to introduce an automated, robust method for analyzing
high dimensional exposure and omic data with relatively modest sample sizes. In the
example used, the challenge was not just from a large number of comparisons (poten-
tial biomarkers), but involve adjusting for potential confounders, all in the context
of a large statistical model and small numbers of biological replicates. Given the
goal is estimation within an unknown statistical model, the technique must involve
data adaptive estimation, though the goal is to still provide trustworthy statistical
inference and estimators that are based on semiparametric efficiency theory. That
is, given the parameter of interest and the statistical model, the choices guiding
the algorithm should not be ad hoc, but based on the relative efficiency of compet-
ing estimators. We have proposed methods that take the existing work on GWAS
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Table 3: Number of significants Probes after BH correction for the mRNA
Data sets using TMLE and adapting by Limma. n is the number of sub-samples
from each of exposed and non-exposed samples. FP TMLE shows the number
of false positive Probes in TMLE method and FP Limma shows the number of
false positive Probes in Limma.
n TMLE FP TMLE Limma FP Limma
8 373 296 25 12
15 1136 312 771 159
20 1353 295 1047 168
25 1357 178 1159 120
30 2009 532 1741 403
and merge them with existing proposals for variable importance, and techniques for
deriving empirical Bayes estimates of the sampling variance in the context of high
dimensional data, for an automated procedure that can data adaptively list the most
promising biomarkers among similar study designs.
We illustrated the method using an example miRNA versus benzene exposure
by applying, on a probe by probe basis, TMLE/SuperLearning to estimate the as-
sociation of each potential marker with exposure. The estimation was conducted
using a combination of SuperLearning and TMLE. In addition, as has been proposed
before, we present a simple way to generalize the Limma approach (Smyth, 2005a),
to robustify small sample inference, that relies on deriving the influence curve of the
estimator of the parameter of interest. The results suggest that one can ameliorate
unstable small-sample inference by combining this asymptotically efficient estimator
(TMLE) with Limma; in our data example, this results in fewer statistically signifi-
cant biomarkers. In addition, because Limma has no impact on the asymptotics (the
adjustment to the within probe inference becomes negligible as sample size grows),
we can rely on the asymptotic theory developed for TMLE.
This combination of existing methods offers many advantages: 1) it estimates
parameters relevant to scientific question, in context of confounders, making no
assumptions about the statistical model, 2) it uses theoretical optimality of loss-
based estimation (Oracle selector) via the SuperLearner algorithm, which does an
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optimal job balancing the variance-bias trade off in small samples by automatically
choosing a level of parsimony to match the information available in the sample, 3)
TMLE estimators reduce residual bias and add an appropriate amount of smoothing,
along with the availability of influence curve based inference unavailable for the
straight substitution estimator, 4) robustifies the inference by using an empirical
Bayes approach (Limma) to derive joint inference with less false positives resulting
from poor estimation of the sampling variability. The result is a theory-driven, data-
adaptive procedure based on pre-specified algorithm with robust statistical inference.
Though the continuing development of new technologies promises new insights into
the relationship of biomarkers, and human health and disease, this procedure helps
to ameliorate the pitfalls of increasing the dimension of the data (and thus avoiding
a commiserate increase in false positive findings) by creating a rigorous statistical
procedure for discovery.
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